Article Versions Notes

Maurya S, Jain A, Rehman MT, Hakamy A, Bantun F, AlAjmi MF, Singh V, Zehra A, Khan F, Haque S, et al. In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules. 2023; 28(4):1652. https://doi.org/10.3390/molecules28041652

Maurya, Satyamvada, Amita Jain, Md Tabish Rehman, Ali Hakamy, Farkad Bantun, Mohamed F. AlAjmi, Vineeta Singh, Aafreen Zehra, Feroz Khan, Shafiul Haque, and et al. 2023. "In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv" Molecules 28, no. 4: 1652. https://doi.org/10.3390/molecules28041652

Maurya, S., Jain, A., Rehman, M. T., Hakamy, A., Bantun, F., AlAjmi, M. F., Singh, V., Zehra, A., Khan, F., Haque, S., & Mishra, B. N. (2023). In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules, 28(4), 1652. https://doi.org/10.3390/molecules28041652